Table 1 Mean of intensity and percentage of co-localization among HS, Trastuzumab and HER2 by confocal microscopy
From: Heparan sulfate mediates trastuzumab effect in breast cancer cells
| Â | Mean of intensity (O.D.) | Co-localization (%) | ||||
|---|---|---|---|---|---|---|
| Â | HS | Trastuzumab | HER2 | Trastuzumab and HS | HS and HER2 | Trastuzumab and HER2 |
MCF7 | 92.3 | 81.8 | 102.2 | 76.2 | 28.1 | 29.2 |
MCF7-HPSE1 | 57.9 | 50.6 | 83.4 | 54.7 | 17.2 | 16.2 |
SKBR3 | 168.6 | 150.2 | 179.9 | 99.5 | 34.8 | 35.2 |